1.
Pathobiology of liver fibrosis: a translational success story
by Lee, Youngmin A
Gut, 2015-05, Vol.64 (5), p.830-841

2.
Stool consistency is strongly associated with gut microbiota richness and composition, enterotypes and bacterial growth rates
by Vandeputte, Doris Doris
Gut, 2015-06-11, Vol.65 (1), p.57-62

3.
Pancreatic cancer
by Vincent, Audrey, PhD
The Lancet (British edition), 2011, Vol.378 (9791), p.607-620

4.
The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controll...
by Baigent, Colin, Prof
The Lancet (British edition), 2011, Vol.377 (9784), p.2181-2192

5.
10-year performance of four models of breast cancer risk: a validation study
by Terry, Mary Beth
The lancet oncology, 2019-04, Vol.20 (4), p.504-517

6.
Prednisone plus cabazitaxel or mitoxantrone for metastatic castration-resistant prostate cancer progressing after docetaxel treatment: a randomised open-label trial
by de Bono, Johann Sebastian, Dr
The Lancet (British edition), 2010, Vol.376 (9747), p.1147-1154

7.
Hereditary diffuse gastric cancer: updated clinical practice guidelines
by Blair, Vanessa R
The lancet oncology, 2020-08, Vol.21 (8), p.e386-e397

8.
Evidence-based detection of pulmonary arterial hypertension in systemic sclerosis: the DETECT study
by Coghlan, J Gerry
Annals of the rheumatic diseases, 2014-07, Vol.73 (7), p.1340-1349

9.
Prevalence, Awareness, Treatment, and Control of Hypertension in China: Results From a National Survey
by Wang, Jinwei
American journal of hypertension, 2014-11-01, Vol.27 (11), p.1355-1361

10.
The natural history of non-alcoholic fatty liver disease in children: a follow-up study for up to 20 years
by Feldstein, A E
Gut, 2009-11, Vol.58 (11), p.1538-1544

11.
Denosumab and bone-metastasis-free survival in men with castration-resistant prostate cancer: results of a phase 3, randomised, placebo-controlled trial
by Smith, Matthew R, Prof
The Lancet (British edition), 2012, Vol.379 (9810), p.39-46

12.
Comparative effectiveness of axitinib versus sorafenib in advanced renal cell carcinoma (AXIS): a randomised phase 3 trial
by Rini, Brian I, Dr
The Lancet (British edition), 2011, Vol.378 (9807), p.1931-1939

13.
Role of viral respiratory infections in asthma and asthma exacerbations
by Busse, William W, Prof
The Lancet (British edition), 2010, Vol.376 (9743), p.826-834

14.
Autologous bone marrow-derived mesenchymal stromal cell treatment for refractory luminal Crohn's disease: results of a phase I study
by Duijvestein, Marjolijn
Gut, 2010-12, Vol.59 (12), p.1662-1669

15.
Long-term intake of dietary fat and risk of ulcerative colitis and Crohn's disease
by Ananthakrishnan, Ashwin N
Gut, 2014-05, Vol.63 (5), p.776-784

16.
High disease activity is associated with an increased risk of infection in patients with rheumatoid arthritis
by Au, Karen
Annals of the rheumatic diseases, 2011-05, Vol.70 (5), p.785-791

17.
Antiretroviral therapy and management of HIV infection
by Volberding, Paul A, Prof
The Lancet (British edition), 2010, Vol.376 (9734), p.49-62

18.
CMT subtypes and disease burden in patients enrolled in the Inherited Neuropathies Consortium natural history study: a cross-sectional analysis
by Fridman, V
Journal of neurology, neurosurgery and psychiatry, 2015-08, Vol.86 (8), p.873-878

19.
Dilemmas in the diagnosis of acute community-acquired bacterial meningitis
by Brouwer, Matthijs C, MD
The Lancet (British edition), 2012, Vol.380 (9854), p.1684-1692

20.
The role of uric acid in the pathogenesis of human cardiovascular disease
by Kanbay, Mehmet
Heart, 2013-06, Vol.99 (11), p.759-766
